TLR2 and myeloid sarcoma: In particular, TLR2 expression is high in MS lesions and TLR2 activation induces the expression of pro-inflammatory cytokines such as IL-6, IL-8, and TNF-α, which are implicated in exacerbated inflammation (Figure 3) [65].